Skip to main content
Premium Trial:

Request an Annual Quote

EMBL European Bioinformatics Institute Awarded £45M from UK Government

NEW YORK (GenomeWeb) — The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) announced today that it has been awarded £45 million ($59.7 million) from the UK government to expand its computing infrastructure.

The EMBL-EBI develops freely available databases, tools, and software to enable the alignment, verification, and visualization of data produced in publicly funded research. It has been a contributor to the Human Cell Atlas and the UK Biobank, among other initiatives.

Cambridgeshire, England-based EMBL-EBI said it will use the funding — which is being made available through UK Research and Innovation's (UKRI) Strategic Priorities Fund — to increase its computing, storage, and building capacity.

"Our ability to process, access, and interrogate large volumes of data is absolutely crucial to scientific discovery in the 21st century, none more so than in health and life sciences where the fields of genomics and molecular biology are fuelling major advances," UKRI Chief Executive Mark Walport said in a statement. "This funding enables EMBL-EBI to continue to grow its global leadership in large biological datasets and bioinformatics, which are used by researchers all over the world, every day of the week."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.